Cargando…

Treatment of invasive Paget’s disease of the vulva in pregnancy: A case report

• Invasive adenocarcinoma of the vulva arising from extramammary Paget’s disease is possible in women of child-bearing age. • Radical vulvectomy, sentinel lymph node biopsy, and inguinal lymphadenectomy are safe and feasible during pregnancy. • Chemotherapy may be used as adjuvant therapy for vulvar...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruce, Kelly H., Tran, Arthur-Quan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340971/
https://www.ncbi.nlm.nih.gov/pubmed/32671169
http://dx.doi.org/10.1016/j.gore.2020.100602
_version_ 1783555135260065792
author Bruce, Kelly H.
Tran, Arthur-Quan M.
author_facet Bruce, Kelly H.
Tran, Arthur-Quan M.
author_sort Bruce, Kelly H.
collection PubMed
description • Invasive adenocarcinoma of the vulva arising from extramammary Paget’s disease is possible in women of child-bearing age. • Radical vulvectomy, sentinel lymph node biopsy, and inguinal lymphadenectomy are safe and feasible during pregnancy. • Chemotherapy may be used as adjuvant therapy for vulvar adenocarcinoma during pregnancy when radiation is contraindicated. • Primary cesarean delivery may be considered for pregnant women with recent vulvar surgery. • Trastuzumab may be considered for maintenance therapy of Her2/Neu positive vulvar cancer in postpartum women.
format Online
Article
Text
id pubmed-7340971
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73409712020-07-14 Treatment of invasive Paget’s disease of the vulva in pregnancy: A case report Bruce, Kelly H. Tran, Arthur-Quan M. Gynecol Oncol Rep Case Report • Invasive adenocarcinoma of the vulva arising from extramammary Paget’s disease is possible in women of child-bearing age. • Radical vulvectomy, sentinel lymph node biopsy, and inguinal lymphadenectomy are safe and feasible during pregnancy. • Chemotherapy may be used as adjuvant therapy for vulvar adenocarcinoma during pregnancy when radiation is contraindicated. • Primary cesarean delivery may be considered for pregnant women with recent vulvar surgery. • Trastuzumab may be considered for maintenance therapy of Her2/Neu positive vulvar cancer in postpartum women. Elsevier 2020-06-15 /pmc/articles/PMC7340971/ /pubmed/32671169 http://dx.doi.org/10.1016/j.gore.2020.100602 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Bruce, Kelly H.
Tran, Arthur-Quan M.
Treatment of invasive Paget’s disease of the vulva in pregnancy: A case report
title Treatment of invasive Paget’s disease of the vulva in pregnancy: A case report
title_full Treatment of invasive Paget’s disease of the vulva in pregnancy: A case report
title_fullStr Treatment of invasive Paget’s disease of the vulva in pregnancy: A case report
title_full_unstemmed Treatment of invasive Paget’s disease of the vulva in pregnancy: A case report
title_short Treatment of invasive Paget’s disease of the vulva in pregnancy: A case report
title_sort treatment of invasive paget’s disease of the vulva in pregnancy: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340971/
https://www.ncbi.nlm.nih.gov/pubmed/32671169
http://dx.doi.org/10.1016/j.gore.2020.100602
work_keys_str_mv AT brucekellyh treatmentofinvasivepagetsdiseaseofthevulvainpregnancyacasereport
AT tranarthurquanm treatmentofinvasivepagetsdiseaseofthevulvainpregnancyacasereport